217 related articles for article (PubMed ID: 23884604)
1. Assessment of the association between XRCC1 Arg399Gln polymorphism and lung cancer in Chinese.
Li Y; Huang Y; Cao YS; Zeng J; Tong WN; Xu SL; Zhuo AS
Tumour Biol; 2013 Dec; 34(6):3681-5. PubMed ID: 23884604
[TBL] [Abstract][Full Text] [Related]
2. Association between XRCC1 Arg399Gln polymorphism and hepatitis virus-related hepatocellular carcinoma risk in Asian population.
Wu D; Jiang H; Gu Q; Zhang D; Li Z
Tumour Biol; 2013 Oct; 34(5):3265-9. PubMed ID: 23780894
[TBL] [Abstract][Full Text] [Related]
3. X-ray repair cross-complementing group 1 Arg399Gln gene polymorphism and susceptibility to colorectal cancer:a meta-analysis.
Zeng FR; Ling Y; Yang J; Tian XC; Yang X; Luo RC
Tumour Biol; 2013 Feb; 34(1):555-63. PubMed ID: 23188703
[TBL] [Abstract][Full Text] [Related]
4. Association between X-ray repair cross-complementation group 1 rs25487 polymorphism and pancreatic cancer risk.
Jiang H; Wu D; Ma D; Lin G; Liang J; Jin J
Tumour Biol; 2013 Dec; 34(6):3417-21. PubMed ID: 23807675
[TBL] [Abstract][Full Text] [Related]
5. XRCC1 Arg399Gln polymorphism contributes to increased risk of colorectal cancer in Chinese population.
Tian Z; Li YL; Liu JG
Mol Biol Rep; 2013 Jul; 40(7):4147-51. PubMed ID: 23712778
[TBL] [Abstract][Full Text] [Related]
6. XRCC1 Arg399Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis.
Liu B; Shen T
Tumour Biol; 2014 Jan; 35(1):507-12. PubMed ID: 24052436
[TBL] [Abstract][Full Text] [Related]
7. Updated assessment of the association of the XRCC1 Arg399Gln polymorphism with lung cancer risk in the Chinese population.
Yang HY; Yang SY; Shao FY; Wang HY; Wang YD
Asian Pac J Cancer Prev; 2015; 16(2):495-500. PubMed ID: 25684477
[TBL] [Abstract][Full Text] [Related]
8. A functional polymorphism in XRCC1 is associated with glioma risk: evidence from a meta-analysis.
Wei X; Chen D; Lv T
Mol Biol Rep; 2013 Jan; 40(1):567-72. PubMed ID: 23096083
[TBL] [Abstract][Full Text] [Related]
9. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and cervical cancer risk: a huge systematic review and meta-analysis.
Li Y; Liu F; Tan SQ; Wang Y; Li SW
PLoS One; 2012; 7(9):e44441. PubMed ID: 22984511
[TBL] [Abstract][Full Text] [Related]
10. The Association Between the XRCC1 Arg399Gln Polymorphism and the Risk of Head and Neck Cancer: An Updated Meta-Analysis Including 14586 Subjects.
Xia S; Wu S; Wang M
Technol Cancer Res Treat; 2021; 20():15330338211033060. PubMed ID: 34278875
[TBL] [Abstract][Full Text] [Related]
11. XRCC1 Arg399Gln genetic polymorphism and the risk of hepatocellular carcinoma: a meta-analysis.
Qi Y; Cui L; Song Y; Li N
Mol Biol Rep; 2014 Feb; 41(2):879-87. PubMed ID: 24390232
[TBL] [Abstract][Full Text] [Related]
12. XRCC1 polymorphisms, cooking oil fume and lung cancer in Chinese women nonsmokers.
Li M; Yin Z; Guan P; Li X; Cui Z; Zhang J; Bai W; He Q; Zhou B
Lung Cancer; 2008 Nov; 62(2):145-51. PubMed ID: 18407370
[TBL] [Abstract][Full Text] [Related]
13. XRCC1 Arg399Gln and Arg194Trp polymorphisms in childhood acute lymphoblastic leukemia risk: a meta-analysis.
Wang R; Hu X; Zhou Y; Feng Q; Su L; Long J; Wei B
Leuk Lymphoma; 2013 Jan; 54(1):153-9. PubMed ID: 22712837
[TBL] [Abstract][Full Text] [Related]
14. XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis.
Wei B; Zhou Y; Xu Z; Ruan J; Zhu M; Jin K; Zhou D; Hu Q; Wang Q; Wang Z; Yan Z
Prostate Cancer Prostatic Dis; 2011 Sep; 14(3):225-31. PubMed ID: 21647176
[TBL] [Abstract][Full Text] [Related]
15. An updated meta-analysis on the association of X-ray repair cross complementing group 1 codon 399 polymorphism with hepatocellular carcinoma risk.
Wang YD; Zhai WL; Wang HY; Xia XQ
Asian Pac J Cancer Prev; 2014; 15(11):4443-8. PubMed ID: 24969866
[TBL] [Abstract][Full Text] [Related]
16. XRCC1 Arg399Gln gene polymorphism and the risk of systemic lupus erythematosus in the Polish population.
Warchoł T; Mostowska A; Lianeri M; Lącki JK; Jagodziński PP
DNA Cell Biol; 2012 Jan; 31(1):50-6. PubMed ID: 21682595
[TBL] [Abstract][Full Text] [Related]
17. An updated meta-analysis between the association of XRCC1 Arg399Gln polymorphism and hepatocellular carcinoma risk.
Zhang XL; Lu Y; Yang S; Peng QL; Wang J; Xie L; Deng Y; He Y; Li TJ; Qin X; Li S
Asian Pac J Cancer Prev; 2014; 15(7):3273-8. PubMed ID: 24815482
[TBL] [Abstract][Full Text] [Related]
18. Associations between XRCC1 Gene Polymorphisms and Coronary Artery Disease: A Meta-Analysis.
Ma WQ; Han XQ; Wang X; Wang Y; Zhu Y; Liu NF
PLoS One; 2016; 11(11):e0166961. PubMed ID: 27870881
[TBL] [Abstract][Full Text] [Related]
19. XRCC1 gene polymorphisms and glioma risk in Chinese population: a meta-analysis.
He LW; Shi R; Jiang L; Zeng Y; Ma WL; Zhou JY
PLoS One; 2014; 9(11):e111981. PubMed ID: 25375625
[TBL] [Abstract][Full Text] [Related]
20. Association of X-ray repair cross complementing group 1 Arg399Gln polymorphisms with the risk of squamous cell carcinoma of the head and neck: evidence from an updated meta-analysis.
Wang Y; Chu X; Meng X; Zou F
PLoS One; 2013; 8(10):e77898. PubMed ID: 24205020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
